HomeTagsRigel Pharmaceuticals

Rigel Pharmaceuticals

Biotechnology

Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO

News Desk - February 23, 2024

Rigel Pharmaceuticals, Inc., announced that it has entered into a definitive agreement to acquire the U.S. rights to GAVRETO from Blueprint Medicines Corporation. GAVRETO...

Biotechnology

Rigel Announces Publication of REZLIDHIA™ Phase 2 Clinical Results in Blood Advances

PR Newswire - February 3, 2023

Rigel Pharmaceuticals, Inc. announced a peer-reviewed publication of data in Blood Advances, which summarizes clinical results from the Phase 2 registrational study of REZLIDHIA™, a...